Highlights Invitae Corporation

Equities

NVTA.Q

US46185L1035

End-of-day quote OTC Markets Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
0.0006 ^USD	-88.00%		-82.86%	-99.90%

04-25	Labcorp beats quarterly estimates on strong testing demand	RE
04-25	Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Labcorp beats quarterly estimates on strong testing demand	04-25	RE
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	04-25	RE
Laboratory Corporation of America Holdings (NYSE:LH) won the bid to acquire substantially all of the assets of Invitae Corporation for approximately $240 million.	04-23	CI
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Substantially all Assets of Invitae Corporation (OTCPK:NVTA.Q).	04-23	CI
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance	04-11	CI
Invitae Launches Update to Invitae Generation: Clinical Variant Modeling Improves Variant Classification	03-12	CI
Earnings Flash (NVTA) INVITAE CORPORATION Posts Q4 Revenue $127.8M	03-06	MT
Invitae Corporation Provides Unaudited Earnings Guidance for the Fourth Quarter and Full Year of 2023	03-06	CI
Invitae gets court approval for five-month bankruptcy sale	02-15	RE
Global markets live: Airbnb, Sony, Uber, Lyft, Nvidia...	02-14
Genetic test maker Invitae files for bankruptcy protection in US	02-14	RE
Invitae Corporation Lists Estimated Assets In The Range Of $500 Mln -$1 Bln - Court Filing	02-14	RE
INVITAE CORPORATION LISTS ESTIMATED LIABILITIES IN THE RANGE OF…	02-14	RE
Genetic test maker Invitae files for voluntary Chapter 11 protection	02-14	RE
Global markets live: BP, Palantir, Infineon, Toyota, UBS...	02-06
Invitae Collaborates With BridgeBio Pharma for Rare Disease Therapeutics	01-30	MT
Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics	01-30	CI
Natera Acquires Reproductive Health Assets From Invitae	01-22	MT
Natera, Inc. completed the acquisition of certain reproductive health assets from Invitae Corporation (NYSE : NVTA) for $52.5 million	01-21	CI
Invitae Sells Certain Assets of YouScript Platform to Aranscia	11-16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Invitae Corporation

Equities

NVTA.Q

US46185L1035

Highlights

Filters